Does FASLODEX Cause Tumour marker increased? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Tumour marker increased have been filed in association with FASLODEX. This represents 3.6% of all adverse event reports for FASLODEX.
5
Reports of Tumour marker increased with FASLODEX
3.6%
of all FASLODEX reports
0
Deaths
2
Hospitalizations
How Dangerous Is Tumour marker increased From FASLODEX?
Of the 5 reports, 2 (40.0%) required hospitalization.
Is Tumour marker increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FASLODEX. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does FASLODEX Cause?
Injection site pain (14)
Arthralgia (11)
Off label use (11)
Bone pain (10)
Pain (10)
Nausea (9)
Back pain (8)
Disease progression (8)
Dyspnoea (8)
Pain in extremity (8)
What Other Drugs Cause Tumour marker increased?
PALBOCICLIB (817)
FULVESTRANT (408)
NIRAPARIB (356)
LETROZOLE (343)
RIBOCICLIB (317)
RUCAPARIB CAMSYLATE (257)
CAPECITABINE (228)
EVEROLIMUS (228)
ELACESTRANT (222)
OLAPARIB (171)
Which FASLODEX Alternatives Have Lower Tumour marker increased Risk?
FASLODEX vs FAVIPIRAVIR
FASLODEX vs FEBUXOSTAT
FASLODEX vs FEDRATINIB
FASLODEX vs FELBAMATE
FASLODEX vs FELIS CATUS HAIR